Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Conditions:   Systemic Lupus Erythematosus (SLE);   Sjogren's Syndrome;   Diffuse Scleroderma;   Inflammatory Myopathy;   ANCA Associated Systemic Vasculitis;   Antiphospholipid Syndrome Intervention:   Biological: BRL-301 Sponsors:   Bioray Laboratories;   Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials